Actinogen Medical Limited (ASX:ACW)
Australia
· Delayed Price · Currency is AUD 0.0210
0.00 (0.00%)
May 28, 2025, 4:10 PM AEST
Actinogen Medical Revenue
Actinogen Medical had revenue of 9.02M AUD in the twelve months ending December 31, 2024, up 88.25% year-over-year. In the fiscal year ending June 30, 2024, Actinogen Medical had annual revenue of 9.93M with 103.18% growth.
Revenue (ttm)
9.02M
Revenue Growth
+88.25%
P/S Ratio
7.29
Revenue / Employee
1.50M
Employees
6
Market Cap
65.78M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2024 | 9.93M | 5.04M | 103.18% |
| Jun 30, 2023 | 4.89M | 1.25M | 34.28% |
| Jun 30, 2022 | 3.64M | 1.66M | 83.47% |
| Jun 30, 2021 | 1.98M | -1.53M | -43.58% |
| Jun 30, 2020 | 3.52M | -1.35M | -27.69% |
| Jun 30, 2019 | Pro | Pro | Pro |
| Jun 30, 2018 | Pro | Pro | Pro |
| Jun 30, 2017 | Pro | Pro | Pro |
| Jun 30, 2016 | Pro | Pro | Pro |
| Jun 30, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| CSL Limited | 24.61B |
| Pro Medicus | 184.58M |
| Cochlear | 2.31B |
| Sonic Healthcare | 9.33B |
| Telix Pharmaceuticals | 783.21M |
| Ramsay Health Care | 17.12B |
| Ansell | 3.00B |
| Regis Healthcare | 1.10B |
Actinogen Medical News
- 4 weeks ago - Actinogen provides pivotal Alzheimer's trial enrolment update and other business news - Benzinga